Study focuses on risks of breast cancer after pre-invasive disease
Updated:5 years, 5 months ago
Updated:5 years, 5 months ago
New Delhi, May 29 (ANI): In a breakthrough study, researchers found that the women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast cancer and of death from breast cancer, compared with general population, finds The study was published in the journal The BMJ today. DCIS is a disease where malignant breast cells are found but have not spread beyond the milk ducts. The risks were more than double those of the general population, even for women diagnosed with low or intermediate grade DCIS, and lasted until at least 20 years after diagnosis, say the researchers. Diagnoses of DCIS have increased substantially in recent years, especially among women attending breast screening programmes. DCIS isn't immediately life-threatening and does usually have a good prognosis. But it can increase the risk of developing invasive breast cancer later on. The extent of this extra risk is uncertain.
Updated:4 years, 9 months ago
Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan
Updated:4 years, 9 months ago
PM Modi joins world leaders in condemning US Capitol siege
Updated:4 years, 10 months ago
Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi
Updated:4 years, 10 months ago
Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan
Updated:4 years, 10 months ago
In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan
Updated:4 years, 10 months ago
Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India